SUMMARY Total serum ferritin and the proportion of serum ferritin binding to concanavalin A (glycosylated ferritin) was measured in 18 healthy volunteers and in 84 patients, eight with primary haemochromatosis, 43 with /-thalassaemia major and secondary iron overload and 33 with chronic liver diseases without iron overload.
Serum ferritin is directly related to body iron stores in normal human subjects.1 However, raised concentrations of serum ferritin are found in some diseases when body iron stores are not increased, as in acute and chronic liver damage,2 malignancy and infections. 3 The majority of isoferritins present in normal human serum bind to the lectin concanavalin A. It has been suggested that ferritin released from damaged tissue does not bind to concanavalin A while ferritin secreted from reticuloendothelial cells is glycosylated, binds to concanavalin A and may provide a more accurate estimate of body iron stores than total serum ferritin.4
We have measured the binding of human serum ferritin to concanavalin A, using sera from healthy volunteers, patients with primary and secondary iron overload and patients with chronic liver disease. The aim of the study was to assess the value of RWGC Liver biopsies were performed percutaneously using a Menghini needle and assessed histologically. The iron content was graded according to the criteria of Scheuer et al. 8 Liver biopsies were performed in all 33 patients with chronic liver disease, and all 33 showed less than grade I siderosis. Seven of eight patients with primary haemochromatosis and eight of 43 patients with thalassaemia major who were all ascorbic acid replete, had liver biopsies performed. The chemical liver iron concentration was measured in these and 10 of the alcoholic patients by the method of Barry and Sherlock.9 The data were analysed using parametric statistical methods. The differences between the means of the groups were analysed using analysis of variance and Tukey's t test.
Results
The results of the laboratory investigations are shown in Table 1 . The total, unbound (or free), and bound serum ferritin were each compared with the serum aminotransferase (AST) used as an estimate of liver cell damage, the units of blood transfused and the chemical liver iron concentration, used as an index of total body iron stores ( Table 2 ). In addition the percentage free ferritin (free ferritin x 100 divided by the total ferritin) and ferritin:AST ratio (total serum ferritin divided by the AST) were calculated and compared with liver iron concentration and AST (Table 2) .
SERUM AST
In every group the total serum ferritin concentration correlated positively with the AST (Table 2) , apart from the patients with primary biliary cirrhosis in whom there was a tendency to significance (0 1 > p > 0-05). In the thalassaemic patients the bound serum ferritin concentration also correlated significantly with the AST but the free ferritin concentration did not. On the other hand, in the other groups including the patients with primary haemochromatosis, it was the free serum ferritin, not the bound, which correlated with the AST.
UNITS OF BLOOD TRANSFUSED
In the 20 thalassaemic patients who had not received chelation therapy the total, free and bound ferritin each correlated with the units of blood transfused (Figs 1-3 ). Neither the bound nor free ferritin correlated more closely than the total ferritin, in these non-chelated patients (Table 2) .
LIVER IRON CONCENTRATION
The total ferritin correlated with the liver iron concentration in the patients with primary haemochromatosis, and in ascorbic acid-replete thalassaemic patients, but no correlation was observed for the patients with alcoholic liver disease. However, while the bound ferritin correlated with liver iron concentration for the thalassaemic patients, in the primary haemochromatosis group it was the free ferritin, not bound, which showed a positive correlation. group iron overload on the one hand, and those with alcoholic liver disease alone on the other hand (Fig. 4) . The patients with iron overload and with alcoholic liver disease both showed a wide range of results. The means of all three groups were significantly increased compared with the normal controls (p < 0-05) and with patients with primary biliary cirrhosis (p < 0 05) (Fig. 4) . We have also confirmed the correlation between the total serum ferritin and liver iron concentration in patients with primary or secondary iron overload.2 12 For this study we excluded /-thalassaemic patients with ascorbic acid deficiency as we have recently shown that in f-thalassaemia major serum ferritin concentrations do not correlate well with liver iron concentration in the presence of ascorbic acid deficiency. '3 Thus the total serum ferritin in iron overload states is only an indirect measure of total body iron stores and is related to, or affected by, a number of variables, including liver iron concentration, liver damage, ascorbic acid deficiency and probably other factors. Moreover, normal serum ferritin concentrations have been reported in precirrhotic idiopathic haemochromatosis.14 It is important, therefore, to estimate the liver iron concentration as an accurate measure of total body iron stores in iron overload states. The liver iron concentration may be estimated from liver biopsy specimens9 or by the newer non-invasive technique of CT scanning.'5 16 We were unable to show a correlation between ferritin: AST ratio and the liver iron concentration in the iron overloaded patients as was previously reported by Prieto et al.2 However, we confirmed their finding that a ferritin:AST ratio of greater than 60 indicates marked iron excess, although iron overload is not excluded by a lower value.
The findings here confirm those of Worwood et a14 that the majority of the various isoferritins present in normal serum bind to the lectin concanavalin A. It has been suggested that the ferritin binding to concanavalin A is glycocylated intracellularly and enters the plasma by secretion rather than by leakage through damaged membranes.417 If glycosylated ferritin is secreted from cells, it might be expected to be related to liver iron concentration rather than to serum AST which is more a measure of liver damage. In the thalassaemic sera, however, the fraction bound to concanavalin A correlated both with the AST and with the liver iron concentration, and showed a similar correlation as the total serum ferritin with the AST and the liver iron concentration.
The present results also show a correlation in the thalassaemic patients between total serum ferritin, bound ferritin and free ferritin with the total units of blood transfused. However, neither bound nor free ferritin showed a better correlation than the total serum ferritin with the units of blood transfused, confirming the findings of Worwood et al. 10 Indeed, they found that the bound ferritin showed a worse correlation than the total serum ferritin with the units transfused in thalassaemic patients.'0 They also demonstrated a relation between bound ferritin and ALT similar to the findings of the present study for bound ferritin and AST. Worwood et al'0 suggested that in thalassaemic patients the level of glycosylated ferritin reaches a maximum after 100 units of blood have been transfused.
In the sera from patients with primary haemochromatosis it was the free serum ferritin, not bound, in contrast to the thalassaemic patients, which correlated with the liver iron concentration and AST. This difference may be due to an effect of chelation therapy as over half the thalassaemic patients had received desferrioxamine. The total serum ferritin, however, showed the closest correlation with the liver iron. Indeed the percentage of the free ferritin to the total ferritin in the different diseases did not discriminate in evaluating iron excess from liver damage.
Approximately 300% of alcoholics have increased liver iron stores,18 which are not accurately reflected by total serum ferritin concentrations.2 18 While there was a close relation between the free ferritin fraction and the AST, unfortunately none of the ferritin sub-fractions correlated with the liver iron concentration in the alcoholic patients.
In contrast to the patients with alcoholic liver disease the major proportion of the increased circulating ferritin in patients with chronic active hepatitis and primary biliary cirrhosis studied here was found to be bound to concanavalin A and did not correlate with serum AST. As there was no evidence of iron overload in these patients, the increase in glycosylated serum ferritin may reflect diminished liver uptake of glycosylated ferritin by damaged liver cells. Halliday et all' have shown that the clearance rate of rat ferritin which is capable of binding to concanavalin A is significantly slower than the clearance of non-bound ferritin. Interestingly, Birgegard had shown that the major proportion of serum isoferritins circulating during acute infection, as normal sera, bind to concanavalin A, '9 although in patients with acute hepatic necrosis, the major proportion of circulating ferritin is not bound to concanavalin A. 9 Ascorbic acid deficiency is known to cause abnormalities in iron and ferritin metabolism,20-23*
We could not, however, detect any difference in the proportion of serum ferritin binding to concanavalin A between ascorbic acid-deficient and replete thalassaemic patients. Thus this study has not shown that measuring the serum ferritin fraction binding to concanavalin A is a more useful way of assessing iron stores in patients with liver damage than the total serum ferritin alone. Measuring this fraction does not appear to offer any advantage over total serum ferritin in assessing body iron stores. 
